Sara Altayeb: ESC 2026 Clinical Pearls for Bleeding on Anticoagulation
Sara Altayeb, Internal Medicine Specialist at Virtual Sudan Clinic, shared on LinkedIn:
”Bleeding on Anticoagulation | ESC 2026 Clinical Pearls:
Managing bleeding isn’t just about stopping drugs, it’s about risk stratification plus targeted reversal plus safe restart.
1. Classify First (ESC Approach):
- Minor / self-limited
- Clinically relevant non-major (CRNM)
- Major / Life-threatening
Severity drives everything!
2. What Defines Major Bleeding?
- Hemodynamic instability
- Hb drop ≥ 2 g/dL or transfusion ≥ 2 units
- Critical site (intracranial, GI, retroperitoneal)
Treat immediately!!
3. Know Your Anticoagulant!
- Warfarin (VKA) – check INR
- DOACs – consider last dose + renal function
- Heparin – short half-life (rapid offset)
Drug plus timing equals management strategy!
4. Management by Severity:
Minor:
- Continue anticoagulant
- Local measures only
CRNM:
- Temporarily hold drug
- Treat source
- Review dose and interactions
Major Bleeding:
- Stop anticoagulant
- ABC resuscitation first
- Use reversal
ESC Reversal Pearls:
- Warfarin – PCC + Vitamin K
- Dabigatran – Idarucizumab
- Apixaban/Rivaroxaban – Andexanet alfa (if available) or PCC
- Heparin – Protamine
5. Restarting Anticoagulation:
Restart early once hemostasis achieved
- High thrombotic risk – restart sooner
- Intracranial bleed – delay and individualize
‘Don’t forget why the patient was anticoagulated.’
Take-Home: Classify – Stabilize – Reverse (if needed) – Restart safely.”

Stay updated on all scientific advances with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk